What the company does
Celltrion, Inc., a biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products. It offers biosimilars, including Remsima for rheumatoid arthritis and inflammatory bowel disease; Truxima for non-hodgkin's lymphoma and chronic lymphocytic leukemia; Herzuma for metastatic breast and gastric cancer; Remsima SC and Yuflyma for rheumatoid arthritis and inflammatory bowel disease; Vegzelma for metastatic colorectal cancer and non-small cell lung cancer; Omlyclo for Asthma and urticaria; Eydenzelt for diabetic macular edema and wet age-related macular degeneration; Steqeyma for psoriasis and inflammatory bowel disease; Stoboclo/Osenvelt for osteoporosis; Avtozma for …
What the weekly tape is saying
068270 closed the latest completed week at 173,000 KRW. The 4-week return is -3.8% and the 12-week return is -14.4%. Trend Signal is inactive, Market Dynamics is -1.08. Setup signature: Risk-first tape with a 25/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 198,930 KRW
- Vs Trend Line
- -13.0%
- Fair Value
- 169,897 KRW
- Vs Fair Value
- 1.8%
- 52W High
- 251,000 KRW
- 52W Low
- 157,740 KRW
- Drawdown
- -31.1%
- Range Position
- 16.4%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 33
- 52W Active Breadth
- 63.5%
- Sector Scope
- KR Healthcare
- Sector Rank
- 20 of 63
- Sector Percentile
- 69.4%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
KR Healthcare
- Tracked Peers
- 63
- 4W Rank
- 9 of 63
- Avg 1W
- -1.0%
- Avg 4W
- -12.7%
- Trend Breadth
- 1.6%
- Positive MD
- 6.3%
KR Biotechnology
- Tracked Peers
- 10
- 4W Rank
- 1 of 10
- Avg 1W
- -0.9%
- Avg 4W
- -11.2%
- Trend Breadth
- 0.0%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.08
- 4W MD Change
- -17.4%
- Relative Strength
- -50.38
- 4W RS Change
- -6.5%
- Expectation
- Undecided
- Probability
- 47.45%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 2.9M
- 13W Average
- 2.8M
- 52W Average
- 2.9M
- Vs 13W
- 1.0x
- Vs 52W
- 1.0x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 4.2%
- 52W Volatility
- 4.7%
- Upside Weeks
- 25
- Downside Weeks
- 27
- Downside Breadth
- 51.9%
- Avg Gain / Loss
- 3.7% / -2.9%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- KSC
- Country
- KR
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- KRW
- Market Cap
- 41868.6B
Opportunity signals
- Price is above Fair Value, showing premium demand versus the model.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 173,000 KRW | 0.9% | 198,930 KRW | 169,897 KRW | -1.08 | -50.38 | 2.9M | Off |
| 5 Jun 2026 | 171,400 KRW | -6.7% | 199,673 KRW | 169,748 KRW | -0.93 | -51.80 | 2.8M | Off |
| 29 May 2026 | 183,714 KRW | -2.9% | 199,699 KRW | 169,631 KRW | -0.79 | -51.00 | 3.2M | Off |
| 22 May 2026 | 189,238 KRW | 5.2% | 199,404 KRW | 169,461 KRW | -0.85 | -46.32 | 3.6M | Off |
| 15 May 2026 | 179,810 KRW | -4.8% | 198,836 KRW | 169,253 KRW | -0.92 | -47.31 | 4.5M | Off |
| 8 May 2026 | 188,952 KRW | -1.0% | 198,651 KRW | 169,111 KRW | -1.03 | -45.40 | 3.4M | Off |
| 1 May 2026 | 190,952 KRW | -4.1% | 198,115 KRW | 168,867 KRW | -1.14 | -38.17 | 1.9M | Off |
| 24 Apr 2026 | 199,048 KRW | 0.7% | 197,586 KRW | 168,589 KRW | -1.15 | -35.17 | 2.1M | Off |
| 17 Apr 2026 | 197,619 KRW | 3.9% | 196,859 KRW | 168,246 KRW | -1.04 | -33.46 | 2.3M | Off |
| 10 Apr 2026 | 190,190 KRW | 2.3% | 195,865 KRW | 167,956 KRW | -0.92 | -33.09 | 2.4M | Off |
| 3 Apr 2026 | 186,000 KRW | -9.7% | 195,225 KRW | 167,758 KRW | -0.68 | -29.57 | 2.6M | On |
| 27 Mar 2026 | 206,000 KRW | 2.0% | 194,635 KRW | 167,492 KRW | -0.27 | -23.87 | 2.8M | On |
| 20 Mar 2026 | 202,000 KRW | -1.7% | 193,332 KRW | 167,041 KRW | 0.26 | -30.53 | 2.2M | On |
| 13 Mar 2026 | 205,500 KRW | -3.3% | 192,367 KRW | 166,638 KRW | 0.76 | -26.46 | 2.6M | On |